Keyword Connections

drug design

Journals

9

1 European journal of medicinal chemistry

2 PloS one

3 Dalton transactions (Cambridge, England : 2003)

4 chembiochem

5 medicinal chemistry (shariqah (united arab emirates))

6 journal of pharmaceutical sciences

7 Journal of biomolecular structure & dynamics

8 Future medicinal chemistry

9 biophysical chemistry

Research Groups

0

No Research Group Connected

Bibliographies

30

1 The Application of Isoacyl Structural Motifs in Prodrug Design and Peptide Chemistry.

2 Using mobile technology to engage sexual and gender minorities in clinical research.

3 Chalcones as a basis for computer-aided drug design: innovative approaches to tackle malaria.

4 Commentary on the Benefits of US Pharmacopeial Standards: A Generic Pharmaceutical Industry Survey.

5 Molecular Docking studies reveals Rhein from rhubarb (Rheum rhabarbarum) as a putative inhibitor of ATP-binding Cassette Super Family G member 2.

6 Protonation states of central amino acids in a zinc metalloprotease complexed with inhibitor: Molecular mechanics optimizations and ab initio molecular orbital calculations.

7 prospects for circumventing aminoglycoside kinase mediated antibiotic resistance

8 fluorinated carbohydrates as lectin ligands: 19f-based direct std monitoring for detection of anomeric selectivity

9 the receptor binding domain of mers-cov: the dawn of vaccine and treatment development

10 Structural basis for the inhibition of SARS-CoV2 main protease by Indian medicinal plant-derived antiviral compounds.

11 transfer and multi-task learning in qsar modeling: advances and challenges

12 11th national meeting of organic chemistry and 4th meeting of therapeutic chemistry

13 crystal structures of ethyl 6-(4-methylphenyl)-4-oxo-4h-chromene-2-carboxylate and ethyl 6-(4-fluorophenyl)-4-oxo-4h-chromene-2-carboxylate

14 Crystal Structure and Carbohydrate Analysis of Nipah Virus Attachment Glycoprotein: a Template for Antiviral and Vaccine Design

15 Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors

16 Modifications of natural peptides for nanoparticle and drug design.

17 Sulfamates in drug design and discovery: Pre-clinical and clinical investigations

18 Development of Potent Inhibitors of Receptor Tyrosine Kinases by Ligand-Based Drug Design and Target-Biased Phenotypic Screening.

19 Structure-based stabilization of non-native protein-protein interactions of coronavirus nucleocapsid proteins in antiviral drug design

20 Latest trends in structure based drug design with protein targets.

21 indole-3-carbonitriles as dyrk1a inhibitors by fragment-based drug design

22 prodrug design, synthesis and pharmacokinetic evaluation of (3′r, 4′r)-3-hydroxymethyl-4-methyl-3′, 4′-di-o-(s)-camphanoyl-(+)-cis-khellactone

23 new small-molecule drug design strategies for fighting resistant influenza a

24 gpcr conformations: implications for rational drug design

25 rational drug design and synthesis of molecules targeting the angiotensin ii type 1 and type 2 receptors

26 direct and indirect drug design approaches for the development of novel tricyclic antipsychotics: potential 5-ht2a antagonist

27 trpv1: a target for rational drug design

28 molecular docking and structure-based drug design strategies

29 novel anthranilamide-based fxa inhibitors: drug design, synthesis and biological evaluation

30 Disposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design